Skip to main content
Clinical Trials/ISRCTN82731440
ISRCTN82731440Completed未知

A randomised controlled trial to investigate the clinical and cost effectiveness of adding an ablation device-based maze procedure as a routine adjunct to elective cardiac surgery for patients with pre-existing atrial fibrillation

Papworth Hospital NHS Foundation Trust (UK)0 sites352 target enrollmentStarted: April 4, 2008Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
352

Study Overview

Brief Summary

2018 Results article in https://www.ncbi.nlm.nih.gov/pubmed/29701167 results 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35348642/ five-year results (added 30/03/2022)

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1. Age over 18, both males and females
  • 2. Patients will have elective cardiac surgery planned (coronary surgery, valve surgery, combined coronary and valve surgery, any other cardiac surgery requiring cardiopulmonary bypass)
  • 3. Patients will have a history of documented atrial fibrillation (chronic, persistent or paroxysmal) beginning more than 3 months before entry into the study
  • 4. All patients will provide written informed consent to participation

Exclusion Criteria

  • 1. Patients with previous cardiac operations
  • 2. Patients having emergency or salvage cardiac operations
  • 3. Patients whose surgery will not involve cardiopulmonary bypass
  • 4. Patients who are unlikely to be available for follow-up over a two-year period
  • 5. Patients who are deemed not competent to provide consent

Investigators

Sponsor
Papworth Hospital NHS Foundation Trust (UK)

Similar Trials